Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Apple and Salesforce are doing well while the AI buildout sector reels. Consumer and healthcare names are coming to the fore. The post Apple, Salesforce Lead Five Stocks Near Buy Points appeared first on Investor’s Business Daily.
Liquidia stock skyrocketed Wednesday on settlement deal with United Therapeutics that allows its drug to stay on the market. The post Liquidia And United Therapeutics Settle; But Only One Stock Skyrocketed appeared first on Investor’s Business Daily.
Boosted by its exclusive agreement with Regeneron, Kiniksa Pharmaceuticals stands among the top biotech stocks to watch. The post Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight appeared first on Investor’s Business Daily.
Johnson & Johnson stock fell early Tuesday as the conflict in the Middle East weighted on medical device sales. The post Health Bellwether J&J Slumps As Middle East Conflict Hampers Medtech Sales appeared first on Investor’s Business Daily.
Biotech stocks have slumped from their August highs. But experts say renewed M&A, likely coming, could catalyze them. The post Why A Biotech M&A Wave May Hit This Winter appeared first on Investor’s Business Daily.
Harmony Biosciences stock took a tumble Monday after its announced the transition of current CEO Jeffrey Dayno at the end of the year. The post Harmony Bio CEO Plans His Exit, And Shares Take An Unharmonious Hit appeared first on…
Bristol Myers Squibb scored two Phase 3 wins on Monday in lung disease and cancer. The stock rose, while a key rival plummeted. The post Bristol Myers Scores Two Phase 3 Wins, But A Key Rival Plummets On One appeared…
First Tracks Biotherapeutics posted “impressive” results for its celiac disease treatment Monday, and the IPO stock surged by double digits. The post Why This IPO Stock, An AnaptysBio Spinoff, Just Skyrocketed More Than 25% appeared first on Investor’s Business Daily.
Teva stock surged Friday after the FDA approved its schizophrenia drug, a once-monthly injectable treatment for the disease. The post Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval appeared first on Investor’s Business Daily.
Viatris pledged Thursday to buy small biotech company Pacira Biosciences for $1.65 billion, sending Pacira stock skyrocketing. The post Pacira Biosciences Snags $1.65 Billion Viatris Takeover Deal; Shares Fly appeared first on Investor’s Business Daily.
